Vascular effects, efficacy and safety of nintedanib in patients with advanced, refractory colorectal cancer: a prospective phase I subanalysis
Crossref DOI link: https://doi.org/10.1186/1471-2407-14-510
Published Online: 2014-07-11
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mross, Klaus
Büchert, Martin
Frost, Annette
Medinger, Michael
Stopfer, Peter
Studeny, Matus
Kaiser, Rolf
License valid from 2014-07-11